FR2929943B1 - Sels de quinoleines 2-substituees - Google Patents

Sels de quinoleines 2-substituees

Info

Publication number
FR2929943B1
FR2929943B1 FR0802072A FR0802072A FR2929943B1 FR 2929943 B1 FR2929943 B1 FR 2929943B1 FR 0802072 A FR0802072 A FR 0802072A FR 0802072 A FR0802072 A FR 0802072A FR 2929943 B1 FR2929943 B1 FR 2929943B1
Authority
FR
France
Prior art keywords
substituted quinoline
quinoline salts
salts
substituted
quinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0802072A
Other languages
English (en)
Other versions
FR2929943A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut de Recherche pour le Developpement IRD
Original Assignee
Institut de Recherche pour le Developpement IRD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut de Recherche pour le Developpement IRD filed Critical Institut de Recherche pour le Developpement IRD
Priority to FR0802072A priority Critical patent/FR2929943B1/fr
Priority to BRPI0907310A priority patent/BRPI0907310A2/pt
Priority to EP09754057A priority patent/EP2271343A1/fr
Priority to PCT/FR2009/000425 priority patent/WO2009144407A1/fr
Priority to US12/937,878 priority patent/US8344145B2/en
Publication of FR2929943A1 publication Critical patent/FR2929943A1/fr
Application granted granted Critical
Publication of FR2929943B1 publication Critical patent/FR2929943B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/10—Quaternary compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0802072A 2008-04-15 2008-04-15 Sels de quinoleines 2-substituees Expired - Fee Related FR2929943B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0802072A FR2929943B1 (fr) 2008-04-15 2008-04-15 Sels de quinoleines 2-substituees
BRPI0907310A BRPI0907310A2 (pt) 2008-04-15 2009-04-14 molécula, processo para a fabricação da forma cristalina de uma molécula, medicamento e uso de uma molécula
EP09754057A EP2271343A1 (fr) 2008-04-15 2009-04-14 Sels de quinoleines 2-substituees
PCT/FR2009/000425 WO2009144407A1 (fr) 2008-04-15 2009-04-14 Sels de quinoleines 2-substituees
US12/937,878 US8344145B2 (en) 2008-04-15 2009-04-14 Salts of 2-substituted quinolines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0802072A FR2929943B1 (fr) 2008-04-15 2008-04-15 Sels de quinoleines 2-substituees

Publications (2)

Publication Number Publication Date
FR2929943A1 FR2929943A1 (fr) 2009-10-16
FR2929943B1 true FR2929943B1 (fr) 2010-09-24

Family

ID=39944249

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0802072A Expired - Fee Related FR2929943B1 (fr) 2008-04-15 2008-04-15 Sels de quinoleines 2-substituees

Country Status (5)

Country Link
US (1) US8344145B2 (fr)
EP (1) EP2271343A1 (fr)
BR (1) BRPI0907310A2 (fr)
FR (1) FR2929943B1 (fr)
WO (1) WO2009144407A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8415483B2 (en) 2010-12-22 2013-04-09 Astrazeneca Ab Compounds and their use as BACE inhibitors
EP2780321B1 (fr) 2011-10-10 2015-12-30 Astrazeneca AB Inhibiteurs de mono fluoro-bêta-secretase
US10548882B2 (en) * 2012-06-21 2020-02-04 Astrazeneca Ab Camsylate salt

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682107B1 (fr) * 1991-10-03 1995-04-21 Orstom Inst Fs Rech Scient Quinoleines 2-substituees pour le traitement des leishmanioses.
FR2819507B1 (fr) * 2001-01-17 2007-09-28 Inst Rech Developpement Ird Quinoleines substituees pour le traitement de co-infections a protozoaires et a retrovirus
HUP0500683A3 (en) * 2005-07-14 2009-03-30 Egis Gyogyszergyar Nyilvanosan New arylpiprazole salts for producing pharmaceutical composition

Also Published As

Publication number Publication date
WO2009144407A1 (fr) 2009-12-03
US20110144154A1 (en) 2011-06-16
EP2271343A1 (fr) 2011-01-12
US8344145B2 (en) 2013-01-01
BRPI0907310A2 (pt) 2017-11-07
FR2929943A1 (fr) 2009-10-16

Similar Documents

Publication Publication Date Title
BRPI0907435A2 (pt) Derivados de 5-flúor pirimidina
BR112012000763A2 (pt) derivados de piridin-4-ila
BRPI0906436A2 (pt) Derivados de ftalazinona
BRPI0916353A2 (pt) dispositivos de remodelação
DK2376490T3 (da) Imidazopyridinforbindelser
BRPI1013246A2 (pt) derivados de benzofuralina
BR112012002828A2 (pt) derivados de 5-fluorpirimidinona
BRPI0918760A2 (pt) compostos morfinanos
BRPI0914657A2 (pt) piridin-2-onae piridazin-3-onas substituídas
DK2308877T3 (da) Imidazopyridin-2-on-derivater
BRPI0919447A2 (pt) derivados do ácido 1-amino-2-ciclobutiletilborônico
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI1015921A2 (pt) agonistas de gpr119
BRPI1011683A2 (pt) derivado isoquinolina substituída
BRPI0923497A2 (pt) derivados de piridazinona
BRPI0922466A2 (pt) sais
FIC20230025I1 (fi) neratinibi
BRPI1013844A2 (pt) derivados de piridina-isoxazol
BRPI0920496A2 (pt) derivados substituídos de pirimidina etriazina
DK2275414T3 (da) Cyclopentylacrylamidderivat
DK2837348T3 (da) Kryokirurgiske fremgangsmåder
BRPI1014454A2 (pt) derivados de isoxazol-pirazol
BRPI1013493A2 (pt) composto de pirimidina
ATE545635T1 (de) Substituierte n-oxidpyrazinderivate

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20161230